These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
584 related articles for article (PubMed ID: 10215666)
1. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666 [TBL] [Abstract][Full Text] [Related]
2. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate. Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423 [TBL] [Abstract][Full Text] [Related]
3. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55. Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327 [TBL] [Abstract][Full Text] [Related]
4. [3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated efflux. Johnson RA; Eshleman AJ; Meyers T; Neve KA; Janowsky A Synapse; 1998 Sep; 30(1):97-106. PubMed ID: 9704886 [TBL] [Abstract][Full Text] [Related]
6. Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes. Silverthorn ML; Dersch CM; Baumann MH; Cadet JL; Partilla JS; Rice KC; Carroll FI; Becketts KM; Brockington A; Rothman RB J Pharmacol Exp Ther; 1995 Apr; 273(1):213-22. PubMed ID: 7714769 [TBL] [Abstract][Full Text] [Related]
7. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex. Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876 [TBL] [Abstract][Full Text] [Related]
8. Studies of the biogenic amine transporters. XI. Identification of a 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR12909) analog that allosterically modulates the serotonin transporter. Nightingale B; Dersch CM; Boos TL; Greiner E; Calhoun WJ; Jacobson AE; Rice KC; Rothman RB J Pharmacol Exp Ther; 2005 Aug; 314(2):906-15. PubMed ID: 15860577 [TBL] [Abstract][Full Text] [Related]
9. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain. Boja JW; Mitchell WM; Patel A; Kopajtic TA; Carroll FI; Lewin AH; Abraham P; Kuhar MJ Synapse; 1992 Sep; 12(1):27-36. PubMed ID: 1411961 [TBL] [Abstract][Full Text] [Related]
10. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding. Wall SC; Innis RB; Rudnick G Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a recombinant human dopamine transporter in multiple cell lines. Eshleman AJ; Neve RL; Janowsky A; Neve KA J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409 [TBL] [Abstract][Full Text] [Related]
12. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization. Staley JK; Basile M; Flynn DD; Mash DC J Neurochem; 1994 Feb; 62(2):549-56. PubMed ID: 8294917 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and transporter binding properties of 3beta-[4'-(phenylalkyl, -phenylalkenyl, and -phenylalkynyl)phenyl]tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter. Blough BE; Keverline KI; Nie Z; Navarro H; Kuhar MJ; Carroll FI J Med Chem; 2002 Aug; 45(18):4029-37. PubMed ID: 12190324 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters. Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775 [TBL] [Abstract][Full Text] [Related]
15. Selective labeling of the dopamine transporter by the high affinity ligand 3 beta-(4-[125I]iodophenyl)tropane-2 beta-carboxylic acid isopropyl ester. Boja JW; Cadet JL; Kopajtic TA; Lever J; Seltzman HH; Wyrick CD; Lewin AH; Abraham P; Carroll FI Mol Pharmacol; 1995 Apr; 47(4):779-86. PubMed ID: 7723739 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and transporter binding properties of 2,3-diphenyltropane stereoisomers. Comparison to 3beta-phenyltropane-2beta-carboxylic acid esters. Chang AC; Burgess JP; Mascarella SW; Abraham P; Kuhar MJ; Carroll FI J Med Chem; 1997 Apr; 40(8):1247-51. PubMed ID: 9111298 [TBL] [Abstract][Full Text] [Related]
17. Assessment of affinities of beta-CIT, beta-CIT-FE, and beta-CIT-FP for monoamine transporters permanently expressed in cell lines. Okada T; Fujita M; Shimada S; Sato K; Schloss P; Watanabe Y; Itoh Y; Tohyama M; Nishimura T Nucl Med Biol; 1998 Jan; 25(1):53-8. PubMed ID: 9466362 [TBL] [Abstract][Full Text] [Related]